C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage AWK Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain MLP Q1 2024 Earnings Net Loss Persists Stock Declines ABUS Q1 2026 Earnings EPS Miss Reflects Continued RD Investment as Pipeline Progresses Invesco Ltd IVZ Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds GAP Q1 2026 Earnings EPS Misses Estimates as Narrow Beat Fails to Materialize